Business Context and Reporting Period
Pulse Biosciences, Inc. filed this Form 8-K on December 7, 2018, to report the expiration and preliminary results of a previously announced rights offering. The rights offering expired at 5:00 p.m. Eastern Time on December 6, 2018.
Key Financial Metrics
This filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document serves solely to announce the conclusion of the rights offering and references a press release for further details.
Material Changes
The material event reported is the expiration of the rights offering. Subscription rights that were not exercised by the expiration date are no longer exercisable. The filing does not provide comparative financial data or specific subscription numbers within the text provided.
Guidance, Outlook, and Risks
The filing does not contain updated guidance, outlook, or specific risk factors. It directs readers to the attached press release (Exhibit 99.1) for the preliminary results of the offering. The company is identified as an emerging growth company.
Investor Verification Checklist
- Verify the total number of subscription rights exercised and the total capital raised by reviewing the attached press release (Exhibit 99.1).
- Confirm the final terms of the offering and any remaining obligations to the company.
- Check subsequent filings for the impact of the offering on the company's cash position and capital structure.